Ask AI

When Good Isn’t Good Enough: Balancing the Augmentation Equation in MDD

Choosing the next step after inadequate antidepressant response requires more than selecting another medication. These downloadable slides from Psychopharmacology Update 2026 examine the evidence guiding switching and augmentation in major depressive disorder, including newer comparative analyses of adjunctive atypical antipsychotics, strategies for persistent symptoms, and the balance between therapeutic benefit and adverse effects.

Augmentation in MDD

Activity Information

Released: November 18, 2026